Showing 8031-8040 of 8862 results for "".
- Galderma's Restylane Refyne and Restylane Defyne Fillers FDA Approved for “Laugh Lines”https://practicaldermatology.com/news/galdermas-restylane-refyne-and-restylane-defyne-fillers-fda-approved-for-laugh-lines/2458349/The FDA approved two new products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21—Galderma's Restylane Refyne and Restylane Defyne. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkl
- NEWA®, Home-Use RF Skin-Care System Launches From Eclipsehttps://practicaldermatology.com/news/newa-home-use-rf-skin-care-system-launches-from-eclipse/2458350/The DIY at-home beauty device market is exploding, and Eclipse Aesthetics®, LLC., in partnership with EndyMed Medical Ltd., is upping the ante with the
- New Lipedema Fellowship Launcheshttps://practicaldermatology.com/news/new-lipedema-fellowship-launches/2458352/The Lipedema Society is launching an International Surgical Fellowship Program. Led by dermatologic surgeon David Amron, MD, medical director of the Roxbury Institute in Beverly Hills, Calif., the six-month fellowship will equip surgeons with the necessary knowledge, tools and methods req
- CDC Study: Banning Indoor Tanning Among Minors Will Save Lives, Moneyhttps://practicaldermatology.com/news/banning-indoor-tanning-among-minors-will-save-lives-money/2458354/An age restriction on indoor tanning could save thousands of lives and millions of dollars, according to new research published online in the Journal of the American Academy of Dermatology. In December 2015, the U.S. Food and Drug Administration
- Novan: Significant Improvement of Genital Warts with SB206https://practicaldermatology.com/news/novan-significant-improvement-of-genital-warts-with-sb206/2458355/Top-line results from Novan Inc.’s Phase 2 clinical trial with SB206 for the treatment of genital warts caused by human papillomavirus, or HPV show statistically significant benefits, the company reports. The highest dose tested, SB206 12%, demonstrated a st
- Study: Anxiety Linked to Skin Diseasehttps://practicaldermatology.com/news/study-anxiety-linked-to-skin-disease/2458359/Anxiety disorders tend to be followed by skin diseases, according to psychologists at the University of Basel in Switzerland and Ruhr University Bochum in Germany. The study, which appears in the journa
- ASDS Honors Awarded and New Board Members Electedhttps://practicaldermatology.com/news/asds-honors-and-new-board-members/2458362/Four members of the American Society for Dermatologic Surgery (ASDS) recently were recognized with the President’s Award for their extraordinary contributions to the Society or the specialty as a whole, and the ASDS awarded Jeanean D. Carruthers, MD, of Vancouver, British Columbia, Canada,
- Dermatology Scientist Sarah Millar Receives 2016 Focus Award For The Advancement Of Women In Medicinehttps://practicaldermatology.com/news/dermatology-scientist-sarah-millar-receives-2016-focus-award-for-the-advancement-of-women-in-medicine/2458364/Penn dermatology scientist Sarah E. Millar, PhD received the 2016 FOCUS Award for the Advancement of Women in Medicine. Millar, the Albert M. Kligman Endowed Professor and vice chair for basic science research in the department of Dermatology at the Perelman School of Medicine at the Univ
- Merz On The Move: Reflections On Fiscal Year 2015/16https://practicaldermatology.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2458365/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- Study: Anxiety, Depression May Travel with Hyperhidrosishttps://practicaldermatology.com/news/anxiety-depression-may-travel-with-hyperhidrosis/2458367/Individuals with hyperhidrosis are more likely to be anxious or depressed than their colleagues who don’t sweat excessively, new research suggests. Specifically, the prevalence of anxiety and depression was 21.3 percent and 27.2 percent in patients with hyperhidrosis, resp